Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2000Arthritis & RheumatismOpen Access

Basic biology and clinical application of specific cyclooxygenase-2 inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

LCLeslie J. CroffordVanderbilt University Medical Center
Peter E. Lipsky
Peter E. LipskyRutgers, The State University of New JerseyPBPeter C. BrooksMaine Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Crofford et al. (2000) studied this question.

synapsesocial.com/papers/6a1bf875b33628da419d0fc1https://doi.org/10.1002/1529-0131(200001)43:1<4::aid-anr2>3.0.co;2-v
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain.1994 · 1,563 citations
  2. 2Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-21999 · 1,314 citations
  3. 3Subcellular Localization of Prostaglandin Endoperoxide H Synthases-1 and -2 by Immunoelectron Microscopy1998 · 337 citations
  4. 4Pharmacological analysis of cyclooxygenase-1 in inflammation1998 · 812 citations
  5. 5TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue1991 · 1,801 citations